会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • HETEROCHAIN ALIPHATIC POLY-N-OXIDE COPOLYMERS AND VACCINATING AGENTS AND DRUGS BASED THEREON
    • 阿拉伯联合酋长国高分子聚氧乙烯共聚物SOWIE DARAUF BASIERENDE IMPFSTOFFE UND ARZNEIMITTEL
    • EP2586447A1
    • 2013-05-01
    • EP11798436.9
    • 2011-06-20
    • Obchtchestvo S Ogranitchennoi Otvetstvennostyou '' NPO Petrovaks Farm"
    • NEKRASOV, Arkady VasilievichPUCHKOVA, Natalya Grigoryevna
    • A61K31/787C08G73/02C08F8/06A61K39/44A61K47/48A61P39/04A61P39/06A61P37/02
    • A61K31/787A61K31/424A61K31/546A61K45/06C08G73/0627C08G73/0633C08L79/04A61K2300/00
    • The invention relates to the field of synthesizing high molecular weight chemical compounds that exhibit biological activity for the production of highly effective pharmacological preparations and vaccines and, more specifically, to heterochain aliphatic poly-N-oxide copolymers of general formula. (1), where R = N, CH; x = 2 or 4; y = 0 or 2; n = 10 - 1000; q = (0.1 - 0.9)n; z = (0.1 - 0.9)n, which exhibit pharmacological activity, including an antioxidant effect and a therapeutic effect as a detoxicant and immunomodulating agent. Also claimed are: a vaccinating agent comprising an antigen and a formula (1) copolymer as an immunomodulating agent; and a vaccine against hepatitis A and hepatitis B, which contains a vaccine preparation comprising HVA Ag and HBsAg simultaneously or vaccine preparations against hepatitis A and against hepatitis B and a formula (1) heterochain aliphatic poly-N-oxide copolymer, A drug is described which comprises a medicinal substance and a formula (1) copolymer as a carrier. The invention represents a new class of compounds that exhibit a wide range of pharmacological activity and a vaccination effect as well as increased safety in use, and is directed towards increasing manufacturability, cost efficiency and environmental safety in the production of drugs.
    • 本发明涉及合成高分子化合物的领域,该化合物具有用于生产高效药理学制剂和疫苗的生物活性,更具体地说,涉及通式为的杂链脂族聚-N-氧化物共聚物。 (1),其中R = N,CH; x = 2或4; y = 0或2; n = 10-1000; q =(0.1-0.9)n; z =(0.1〜0.9)n,其具有药理活性,包括抗氧化作用和作为除毒剂和免疫调节剂的治疗作用。 还要求的是:包含抗原和式(1)共聚物作为免疫调节剂的疫苗接种剂; 和一种针对甲型和乙型肝炎的疫苗,其中含有包含HVA Ag和HBsAg的疫苗制剂,或者针对乙型肝炎和乙型肝炎的疫苗制剂和式(1)杂链脂族聚-N-氧化物共聚物,描述了一种药物 其包含药物和式(1)共聚物作为载体。 本发明代表了一类新的化合物,其具有广泛的药理活性和疫苗接种效果以及使用中的安全性,并且旨在提高药物生产中的可制造性,成本效率和环境安全性。